FIELD: medicine, pharmacology. SUBSTANCE: heme stimulating agent has the following components, wt. -%: lysine baicaleinate, 15-25; propylene glycol, 35-45; and water, the balance. Agent is used for correction of bone marrow hemopoiesis after effect of ionizing radiation and cytostatics on organism and at hemolytic anemia background. EFFECT: stimulation of bone marrow hemopoiesis suppressed by myeloinhibiting factors. 12 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
AGENT STIMULATING FUNCTIONS OF MONONUCLEAR PHAGOCYTE CELL SYSTEM | 1994 |
|
RU2098080C1 |
GRANULOMONOCYTOPOIESISSTIMULATING PREPARATION AT HYPOPLASTIC STATES OF BLOOD FORMATION | 2001 |
|
RU2182007C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
Authors
Dates
1997-10-27—Published
1994-01-10—Filed